Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jingwei Tian

Showing results (101-110 of 183) with videos related to

Pageof 19
Sort By:
Regulatory Toxicology and Pharmacology : RTP|July 22, 2018
Acute, subchronic oral toxicity, and genotoxicity evaluations of LPM570065, a new potent triple reuptake inhibitorChunmei Li, Wanglin Jiang, Yonglin Gao, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|June 19, 2017
Nonclinical safety of astilbin: A 4-week oral toxicity study in rats with genotoxicity, chromosomal aberration, and mammalian micronucleus testsYonglin Gao, Chunmei Li, Yunzhi Wang, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|March 5, 2013
Three-month subchronic intramuscular toxicity study of rotigotine-loaded microspheres in SD ratsLiang Ye, Xiaolin Guan, Jingwei Tian, et al.
European Journal of Medicinal Chemistry|July 30, 2021
Synthesis and analysis of dihydrotetrabenazine derivatives as novel vesicular monoamine transporter 2 inhibitorsYifei Yang, Dawei Yu, Xiaoyin Zhu, et al.
Journal of Medicinal Chemistry|July 13, 2021
Discovery of the Next-Generation Pan-TRK Kinase Inhibitors for the Treatment of CancerZongliang Liu, Pengfei Yu, Lin Dong, et al.
Basic & Clinical Pharmacology & Toxicology|November 17, 2009
Cardioprotective effect of SMND-309, a novel derivate of salvianolic acid B on acute myocardial infarction in ratsJianxiong Yang, Guanbo Zhang, Jingwei Tian, et al.
Neuropharmacology|March 28, 2026
Targeting ME1 rescues redox-metabolic coordination in ALS: A core effector of NRF2-directed therapyYifan Yang, Yurong Yang, Xiaofan Zhang, et al.
Acta Pharmaceutica Sinica. B|January 26, 2017
Lx2-32c, a novel semi-synthetic taxane, exerts antitumor activity against prostate cancer cells <i>in vitro</i> and <i>in vivo</i>Guangyao Lv, Dengjun Sun, Jingwen Zhang, et al.
Frontiers in Pharmacology|May 8, 2023
Biological evaluation and <i>in silico</i> studies of novel compounds as potent TAAR1 agonists that could be used in schizophrenia treatmentYunjie Wang, Zhaofeng Liu, Jing Lu, et al.
Plos One|March 28, 2020
PCC0208025 (BMS202), a small molecule inhibitor of PD-L1, produces an antitumor effect in B16-F10 melanoma-bearing miceZhengping Hu, Pengfei Yu, Guangying Du, et al.
Pageof 19

Showing results (101-110 of 183) with videos related to

Sort By:
Pageof 19
Regulatory Toxicology and Pharmacology : RTP|July 22, 2018
Acute, subchronic oral toxicity, and genotoxicity evaluations of LPM570065, a new potent triple reuptake inhibitorChunmei Li, Wanglin Jiang, Yonglin Gao, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|June 19, 2017
Nonclinical safety of astilbin: A 4-week oral toxicity study in rats with genotoxicity, chromosomal aberration, and mammalian micronucleus testsYonglin Gao, Chunmei Li, Yunzhi Wang, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|March 5, 2013
Three-month subchronic intramuscular toxicity study of rotigotine-loaded microspheres in SD ratsLiang Ye, Xiaolin Guan, Jingwei Tian, et al.
European Journal of Medicinal Chemistry|July 30, 2021
Synthesis and analysis of dihydrotetrabenazine derivatives as novel vesicular monoamine transporter 2 inhibitorsYifei Yang, Dawei Yu, Xiaoyin Zhu, et al.
Journal of Medicinal Chemistry|July 13, 2021
Discovery of the Next-Generation Pan-TRK Kinase Inhibitors for the Treatment of CancerZongliang Liu, Pengfei Yu, Lin Dong, et al.
Basic & Clinical Pharmacology & Toxicology|November 17, 2009
Cardioprotective effect of SMND-309, a novel derivate of salvianolic acid B on acute myocardial infarction in ratsJianxiong Yang, Guanbo Zhang, Jingwei Tian, et al.
Neuropharmacology|March 28, 2026
Targeting ME1 rescues redox-metabolic coordination in ALS: A core effector of NRF2-directed therapyYifan Yang, Yurong Yang, Xiaofan Zhang, et al.
Acta Pharmaceutica Sinica. B|January 26, 2017
Lx2-32c, a novel semi-synthetic taxane, exerts antitumor activity against prostate cancer cells <i>in vitro</i> and <i>in vivo</i>Guangyao Lv, Dengjun Sun, Jingwen Zhang, et al.
Frontiers in Pharmacology|May 8, 2023
Biological evaluation and <i>in silico</i> studies of novel compounds as potent TAAR1 agonists that could be used in schizophrenia treatmentYunjie Wang, Zhaofeng Liu, Jing Lu, et al.
Plos One|March 28, 2020
PCC0208025 (BMS202), a small molecule inhibitor of PD-L1, produces an antitumor effect in B16-F10 melanoma-bearing miceZhengping Hu, Pengfei Yu, Guangying Du, et al.
Pageof 19